Top Cannabis Investment News, Member Posts, Cannabis Investment Daily Indices and more!

1yr ago Cannabis greenmarketreport Views: 198

-

The Minnesota Board of Pharmacy filed a civil suit against a trio of cannabis edibles companies for selling overly potent and illegally manufactured products that resulted in several teenagers being taken to the hospital.

According to the Star Tribune, the board filed its lawsuit against Northland Vapor Company Moorhead, Northland Vapor Company Bemidji, and Wonky Confections, all of whom it says are responsible for selling infused gummy bears that contained more than 50 times the legal limit of THC.

A unique Minnesota law allows for THC-infused edibles to be sold by practically any retailer in the state, but the edibles must be derived from hemp – not marijuana – and can only contain a maximum of 50 milligrams of THC per package, with a 5 milligram-per-serving limit.

Products sold by the three companies, however, contained as much as 2,500 milligrams of THC, the lawsuit contends.

In addition, some of the products made and sold by the three companies violate a state ban on edibles that resemble traditional candies that could be marketed to children. Specifically, Northland Vapor’s “Death By Gummy Bears” was an egregious rulebreaker, a pharmacy board spokesperson said.

“This group of companies far exceeded those limits and did so in a type of product historically marketed to children,” Pharmacy Board Executive Director Jill Phillips said during a press conference, the Star Tribune reported.

Phillips said that five teens from Iowa became ill after eating some of the gummy bears, and two were admitted to the emergency room.

The Pharmacy Board has seized roughly $7 million worth of products from the three companies and is awaiting a court’s permission to destroy the inventory, the Star Tribune reported. The lawsuit also requests an injunction that would bar the three companies from making and selling illegal edibles.

Minnesota Regulators Sue Edibles Companies Over Potency, Product Violations on Green Market Report.


Today's Cannabis Investment Headlines:

Log In for More
Access Over 250K+ Industry Headlines, Posts and Updates
Not a member yet?

Join AlphaMaven

The Premier Alternative Investment
Research and Due Diligence Platform for Investors

Free Membership for Qualified Investors and Industry Participants
  • Easily Customize Content to Match Your Investment Preferences
  • Breaking News 24/7/365
  • Daily Newsletter & Indices
  • Alternative Investment Listings & LeaderBoards
  • Industry Research, Due Diligence, Videos, Webinars, Events, Press Releases, Market Commentary, Newsletters, Fact Sheets, Presentations, Investment Mandates, Video PitchBooks & More!
  • Company Directory
  • Contact Directory
  • Member Posts & Publications
  • Alpha University Video Series to Expand Investor Knowledge
  • AUM Accelerator Program (designed for investment managers)
  • Over 450K+ Industry Headlines, Posts and Updates
ALL ALPHAMAVEN CONTENT IS FOR INFORMATIONAL PURPOSES ONLY. CONTENT POSTED BY MEMBERS DOES NOT NECESSARILY REFLECT THE OPINION OR BELIEFS OF ALPHAMAVEN AND HAS NOT ALWAYS BEEN INDEPENDENTLY VERIFIED BY ALPHAMAVEN. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. THIS IS NOT A SOLICITATION FOR INVESTMENT. THE MATERIAL PROVIDED HEREIN IS FOR INFORMATIONAL PURPOSES ONLY. IT DOES NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO BUY ANY INTERESTS OF ANY FUND OR ANY OTHER SECURITIES. ANY SUCH OFFERINGS CAN BE MADE ONLY IN ACCORDANCE WITH THE TERMS AND CONDITIONS SET FORTH IN THE INVESTMENT'S PRIVATE PLACEMENT MEMORANDUM. PRIOR TO INVESTING, INVESTORS ARE STRONGLY URGED TO REVIEW CAREFULLY THE PRIVATE PLACEMENT MEMORANDUM (INCLUDING THE RISK FACTORS DESCRIBED THEREIN), THE LIMITED PARTNERSHIP AGREEMENT AND THE SUBSCRIPTION DOCUMENTS, TO ASK SUCH QUESTIONS OF THE INVESTMENT MANAGER AS THEY DEEM APPROPRIATE, AND TO DISCUSS ANY PROSPECTIVE INVESTMENT IN THE FUND WITH THEIR LEGAL AND TAX ADVISERS IN ORDER TO MAKE AN INDEPENDENT DETERMINATION OF THE SUITABILITY AND CONSEQUENCES OF AN INVESTMENT.